CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-30 | Schick Kelly Chief People Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 16,500 | ||
| 2023-08-30 | Fisher Stewart Chief Scientific Officer | Option exercise | +2,250 | 104,737 | ||
| 2023-08-30 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −661 | $2.93 | $2K | 104,076 |
| 2023-08-30 | Fisher Stewart Chief Scientific Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 16,500 | ||
| 2023-08-30 | Boyle Scott N Chief Business Officer | Option exercise | +2,250 | 27,426 | ||
| 2023-08-30 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −661 | $2.93 | $2K | 26,765 |
| 2023-08-30 | Boyle Scott N Chief Business Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 16,500 | ||
| 2023-07-10 | REYNO LEONARD Chief Medical Officer | Grant or award | +61,300 | 61,300 | ||
| 2023-07-10 | REYNO LEONARD Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +276,000 | 276,000 | ||
| 2023-07-03 | Anderson Kenneth Carl Director | Grant or award | +3,976 | $2.83 | $11K | 102,620 |
| 2023-07-03 | Dubin Glenn Director | Grant or award | +3,887 | $2.83 | $11K | 12,560 |
| 2023-07-03 | GROGAN DONNA ROY Director | Grant or award | +4,858 | $2.83 | $14K | 11,738 |
| 2023-06-15 | Anderson Kenneth Carl Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-15 | Bessen Laura Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-15 | DOWNEY BRUCE Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-15 | Dubin Glenn Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-15 | GROGAN DONNA ROY Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-15 | Koppikar Utpal Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-15 | Salter Malcolm Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-04-03 | Dubin Glenn Director | Grant or award | +3,438 | $3.20 | $11K | 8,673 |
Page 12 of 27 · 525 trades